# Phase I/II Study of SCTB39G in Advanced Solid Tumours

> **NCT07077252** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Sinocelltech Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Advanced Malignant Solid Tumor

## Interventions

- **DRUG:** SCTB39G

## Key facts

- **NCT ID:** NCT07077252
- **Lead sponsor:** Sinocelltech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-28
- **Primary completion:** 2027-09-26
- **Final completion:** 2027-10-17
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07077252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07077252, "Phase I/II Study of SCTB39G in Advanced Solid Tumours". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07077252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*